Canada - English - Health Canada

deciphera pharmaceuticals. llc - ripretinib - tablet - 50mg - ripretinib 50mg - antineoplastic agents

Israel - English - Ministry of Health

medison pharma ltd - ripretinib - tablets - ripretinib 50 mg - ripretinib - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumor (gist) who have received prior treatment with 3 or more kinase inhibitors, including imatinib.

Singapore - English - HSA (Health Sciences Authority)

specialised therapeutics asia pte ltd - ripretinib - tablet - ripretinib 50.0 mg

European Union - English - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - antineoplastic agents - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.